Opinion

Video

Biologics Utilization Impacting US Health Care Spending

Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, and Chad Cannon, PharmD, BCCCP, open a panel discussion highlighting specialty biologics and navigating challenges for biosimilar uptake.

Video content above is prompted by the following:

  • How significant is the impact of specialty medications, particularly biologics, on current US health care spending?
  • What have been the major challenges and successes in reducing health care costs through the use of biosimilars?
    • Briefly, what is hindering biosimilar uptake?
    • Where have biosimilars been successful?
  • What are some strategies for successful biosimilar adoption?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
5 experts are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo